[{"id":"af433384-87c1-4543-9d9d-fa60f08304f3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05740956","created_at":"2023-02-23T15:01:09.263Z","updated_at":"2024-07-02T16:35:33.868Z","phase":"Phase 1","brief_title":"A Study of Hansoh (HS)-10502 in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT05740956","lead_sponsor":"Jiangsu Hansoh Pharmaceutical Co., Ltd.","biomarkers":" HRD • MUC16","pipe":" | ","alterations":" HRD","tags":["HRD • MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HRD"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HS-10502"],"overall_status":"Recruiting","enrollment":" Enrollment 318","initiation":"Initiation: 06/09/2023","start_date":" 06/09/2023","primary_txt":" Primary completion: 04/01/2026","primary_completion_date":" 04/01/2026","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2023-10-11"}]